CorMedix Inc.
CRMDBiotechnology
$7.64−6.83%As of Oct 29vs prior close
- Market cap
- $595.5M
- P/E (TTM)
- 3.1×
- P/E (FY1)
- 7.9×
- From 52W high
- −39.98%
- EPS (LTM)
- $2.18
- Revenue (YE25)
- $311.7M
Nomior Score
44
Discounted QualitySpeculativeBottom 37% of the scored universe
Growth24
Quality70
Value86
Momentum18
Resilience38
Growth
+123.49%revenue a year over 9 fiscal years
YE16 $224.1KYE25 $311.7M
Connections
Revenue to profitQ2 YE26
25% of revenue became net profit, down 24 pts on a year.
Who owns it
2funds